Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genome. | Leukemia | 2022 | 36131042 | PubTator, text mining | PubMed |
| Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease. | Cell Host Microbe | 2022 | 36130593 | PubTator, text mining | PubMed |
| EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma. | Nucleic Acids Res | 2022 | 36124657 | PubTator, text mining | PubMed |
| Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia. | Nat Commun | 2022 | 36123353 | PubTator, text mining | PubMed |
| Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies. | Mediterr J Hematol Infect Dis | 2022 | 36119457 | PubTator, text mining | PubMed |
| Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia. | Front Immunol | 2022 | 36119104 | PubTator, text mining | PubMed |
| Potential epigenetic molecular regulatory networks in ocular neovascularization. | Front Genet | 2022 | 36118885 | PubTator, text mining | PubMed |
| Emerging Implications of Phase Separation in Cancer. | Adv Sci (Weinh) | 2022 | 36117111 | PubTator, text mining | PubMed |
| Control of ribosomal RNA synthesis by hematopoietic transcription factors. | Mol Cell | 2022 | 36113481 | PubTator, text mining | PubMed |
| Genomic features of Helicobacter pylori-naïve diffuse-type gastric cancer. | J Pathol | 2022 | 36111561 | PubTator, text mining | PubMed |
| MLL regulates the actin cytoskeleton and cell migration by stabilising Rho GTPases via the expression of RhoGDI1. | J Cell Sci | 2022 | 36111497 | PubTator, text mining | PubMed |
| Pluripotency of periodontal ligament and dental pulp cells is induced by intercellular communication via the CDX2/Oct-4/Sox2 pathway. | Ann Transl Med | 2022 | 36111038 | PubTator, text mining | PubMed |
| Know when to fold 'em: Polycomb complexes in oncogenic 3D genome regulation. | Front Cell Dev Biol | 2022 | 36105358 | PubTator, text mining | PubMed |
| [Retracted] MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway. | Int J Oncol | 2022 | 36102301 | PubTator, text mining | PubMed |
| Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters. | iScience | 2022 | 36097617 | PubTator, text mining | PubMed |
| Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease. | Nat Commun | 2022 | 36097025 | PubTator, text mining | PubMed |
Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis. | Front Genet | 2022 | 36092919 | PubTator, text mining | PubMed |
| Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma. | Front Genet | 2022 | 36092911 | PubTator, text mining | PubMed |
| Integrated analysis of the M2 macrophage-related signature associated with prognosis in ovarian cancer. | Front Oncol | 2022 | 36091124 | PubTator, text mining | PubMed |
| Comprehensive comparison between azacytidine and decitabine treatment in an acute myeloid leukemia cell line. | Clin Epigenetics | 2022 | 36089606 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=36